Your Search for AIDS Wasting Syndrome matched 117 Documents (Page 1 of 4).
Results Indexed by relevance.

1. (BW) (THERATECH/MASS-GNRL-HOSP)(THRT) Boston study to evaluate new testosterone patch for treatment of women with AIDS wasting syndrome (70%)
Abstract: BOSTON--(BUSINESS WIRE)--Sept. 4, 1996--The Massachusetts General Hospital, a teaching hospital of the Harvard Medical School, and TheraTech Inc. (NASDAQ:THRT), Salt Lake City, Wednesday announced initiation of a pilot study to assess a new approach for treating women with the AIDS wasting syndrome. The treatment uses ...
http://www.aegis.org/news/bw/1996/bw960901.html
File Name: bw960901.html, Size: 11KB, Last Modified: Tuesday, March 06, 2007 at 5:32:32 PM

2. AEGiS-13IAC: Cost effectiveness analysis of serostim versus oxandrin in the treatment of AIDS wasting syndrome. (70%)
Abstract: <p><b>BACKGROUND:</b> Both anabolic steroids and recombinant human growth hormone (rhGH) are used in the management of AIDS Wasting Syndrome (AWS), yet the more cost-effective treatment remains unknown. <p><b>OBJECTIVE:</b> Compare the cost-effectiveness of rhGH ( ...
http://www.aegis.org/conferences/iac/2000/mopec2477.html
File Name: mopec2477.html, Size: 8KB, Last Modified: Sunday, July 09, 2000 at 8:12:04 PM

3. AEGiS-13IAC: Cost effectiveness of serostim versus megace in the treatment of AIDS wasting syndrome. (70%)
Abstract: <p><b>BACKGROUND:</b> Numerous modalities for the treatment of AIDS Wasting Syndrome (AWS) exist, yet the more cost-effective treatment remains unknown. <p><b>OBJECTIVE:</b> Calculate and contrast the cost-effectiveness ratios of recombinant human growth hormone (rhGH) ( Serostim ) and megestrol acetate ( ...
http://www.aegis.org/conferences/iac/2000/mopec2478.html
File Name: mopec2478.html, Size: 7KB, Last Modified: Sunday, July 09, 2000 at 8:12:04 PM

4. The use of testosterone in the AIDS wasting syndrome. (70%)
Abstract: AIDS wasting syndrome (AWS) is a complication of advanced HIV disease characterized by loss of lean body mass. The loss of endogenous anabolic hormones, such as testosterone, is thought to contribute to muscle loss. Studies have shown that more than half of male AIDS patients have low testosterone levels, and increase ...
http://www.aegis.org/aidsline/2000/may/a0050679.html
File Name: a0050679.html, Size: 9KB, Last Modified: Sunday, May 28, 2000 at 8:12:04 PM

5. Monitoring changes in fat-free mass in HIV-positive men with hypotestosteronemia and AIDS wasting syndrome treated with gonadal hormone replacement therapy [see comments] (70%)
Abstract: OBJECTIVE: To compare methods for assessing changes in body composition during gonadal hormone replacement therapy in a group of HIV-positive men with AIDS wasting syndrome. DESIGN: The study included a 21-day, double-blind, randomized, placebo-controlled inpatient intervention and a 12-week open-label intervention. T ...
http://www.aegis.org/aidsline/1999/aug/a9981008.html
File Name: a9981008.html, Size: 11KB, Last Modified: Saturday, August 28, 1999 at 8:12:04 PM

6. The Use of Testosterone in AIDS Wasting Syndrome (70%)
Abstract: The use of testosterone may help in staving off AIDS wasting syndrome (AWS), according to recent data. Studies have indicated that testosterone levels are low in over half of all men with AIDS, and hypogonadism is seen to increase with the progression of the disease. Hypogonadism is often related to the effects of seve ...
http://www.aegis.org/news/ads/1999/ad990704.html
File Name: ad990704.html, Size: 10KB, Last Modified: Monday, May 03, 1999 at 3:00:00 PM

7. AIDS wasting syndrome as an enterometabolic disorder: the gut hypothesis. (70%)
Abstract: There is an interesting relationship between the HIV virus, the health of the gastrointestinal tract, and AIDS wasting syndrome, involving Tumor Necrosis Factor alpha (TNF alpha), specific and non-specific immunity in the gut, gut permeability, and oxidative stress. It is hypothesized that the progression of HIV to fu ...
http://www.aegis.org/aidsline/1998/aug/m9880863.html
File Name: m9880863.html, Size: 8KB, Last Modified: Saturday, August 29, 1998 at 6:29:23 AM

8. Diagnosis and treatment of endocrine disorders in the HIV-infected patient. (70%)
Abstract: Hormonal disturbances are common in patients with advanced HIV disease, and these imbalances may contribute to the loss of muscle and lean body mass. The most common endocrine manifestations related to HIV disease are reviewed and potential therapeutic strategies for combating AIDS wasting syndrome are discussed. Disc ...
http://www.aegis.org/aidsline/1998/aug/m9880187.html
File Name: m9880187.html, Size: 8KB, Last Modified: Saturday, August 29, 1998 at 6:29:23 AM

9. The etiology of wasting in the human immunodeficiency virus and acquired immunodeficiency syndrome. (70%)
Abstract: Wasting is a debilitating complication of the human immunodeficiency virus/acquired immunodeficiency syndrome HIV/AIDS) and is a major cause of morbidity and mortality. The etiology of wasting in HIV/AIDS is complex and its origins are multifactorial. Both patterns of simple starvation and the more complex metabolic a ...
http://www.aegis.org/aidsline/1998/aug/m9880250.html
File Name: m9880250.html, Size: 8KB, Last Modified: Saturday, August 29, 1998 at 6:29:23 AM

10. AEGiS-12IAC: Long-term effects of androgen administration in men with AIDS wasting. (70%)
Abstract: <p><b>BACKGROUND:</b> The development of successful anabolic strategies to reverse loss of lean body mass is of critical importance in men with the AIDS wasting syndrome (AWS). Androgen deficiency occurs in over half of all men with advanced HIV disease and may contribute to the wasting syndrome. <p><b>OBJECTIVE:</ ...
http://www.aegis.org/conferences/iac/1998/32176.html
File Name: 32176.html, Size: 8KB, Last Modified: Sunday, June 28, 1998 at 8:12:04 PM

11. NIH conference on AIDS wasting syndrome. National Institutes of Health. (70%)
Abstract: Findings that were presented at the National Institute of Health NIH) Conference on AIDS Wasting Syndrome are discussed. Discussions include an overview of wasting, wasting in pediatric AIDS, the influence of exercise and diet in wasting, the manipulation of protein synthesis and metabolism in treating wasting, and th ...
http://www.aegis.org/aidsline/1998/mar/m9830153.html
File Name: m9830153.html, Size: 8KB, Last Modified: Sunday, March 29, 1998 at 6:29:23 AM

12. Growth hormone cut down at the pass. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. (70%)
Abstract: The Food and Drug Administration ( FDA ) rejected Serono Laboratories human growth hormone for the treatment of AIDS wasting syndrome. Serono failed to present a compelling case, and its data and test design were widely criticized. AIDS wasting syndrome is defined as the involuntary lo ...
http://www.aegis.org/aidsline/1996/sep/m9690163.html
File Name: m9690163.html, Size: 8KB, Last Modified: Saturday, September 28, 1996 at 8:12:04 PM

13. D-xylose malabsorption: characteristic finding in patients with the AIDS wasting syndrome and chronic diarrhea. (70%)
Abstract: The AIDS wasting syndrome (AWS) is characterized by > 10% loss of baseline body weight during 6 months and may occur in patients with or without associated chronic diarrhea. To determine whether the presence of small-intestinal malabsorption is associated with the development of AWS in human immunodeficiency virus (HI ...
http://www.aegis.org/aidsline/1993/mar/m9330910.html
File Name: m9330910.html, Size: 10KB, Last Modified: Sunday, March 28, 1993 at 8:12:04 PM

14. AEGiS-05IAC: HIV associated myopathy: features in 21 patients and role of AZT. (70%)
Abstract: To describe the features of 21 patients with HIV-associated myopathy as well as the role of AZT in this disorder. <p><b>METHODS</b>: All patients were evaluated at Mount Sinai Hospital. Electrophysiological testing included nerve conduction studies and needle electromyography (EMG). Muscle biopsies were processed by ...
http://www.aegis.org/conferences/iac/1989/mbp330.html
File Name: mbp330.html, Size: 6KB, Last Modified: Sunday, June 04, 1989 at 7:12:04 PM

15. Growth Hormone Helps AIDS Patients Gain Weight--Study (35%)
Abstract: AEGIS, AIDS Daily Summary, HIV, AIDS, HIV infection, opportunistic infections. var gaJsHost = (https: = document.location.protocol) ? "https:ssl. : "http:www. document.write(unescape(3Cscript src= + gaJsHost + "google-analytics.com/ga.js' type=text/javascript'3E%3C/script%3E"ion" CONTENT=A study cond ...
http://www.aegis.org/news/ads/1994/ad941838.html
File Name: ad941838.html, Size: 10KB, Last Modified: Sunday, January 04, 2009 at 6:49:00 PM

16. Ask the Doc (35%)
Abstract: HAART, organs, cd-4, erythrocyte sedimentation rate, nutrients, HIV, AIDS, HIV infection, HIV positive, surgery. Important note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date. Question:Respected Sir/Madam, My questions are as follows:. ...
http://www.aegis.org/askdoc/askd040802.html
File Name: askd040802.html, Size: 7KB, Last Modified: Tuesday, March 06, 2007 at 7:15:25 PM

17. AEGiS-CATIE: TraitementSida 91: Testostérone contre la perte de poids (35%)
Abstract: Le VIH/sida peut s'accompagner d'une perte de poids non reliée à la diarrhée ou à des infections intestinales. Dans certains cas, la cause peut être une réduction de l'appétit ou une mauvaise absorption des éléments nutritifs. Dans d'autres cas, il peut y avoir une sécrétion insuffisante de testostérone. Des anomalies ...
http://www.aegis.org/pubs/catie/1998/catf9105.html
File Name: catf9105.html, Size: 10KB, Last Modified: Tuesday, March 06, 2007 at 6:43:37 PM

18. AEGiS-CATIE: Testosterone for weight loss (35%)
Abstract: HIV/AIDS may be accompanied by weight loss unrelated to diarrhea or intestinal infections. In some cases, reduced appetite and malabsorption may be factors. In other cases, a deficiency in the production of testosterone and abnormalities in the activity of growth hormone may be involved in both men and women. ...
http://www.aegis.org/pubs/catie/1998/cate9105.html
File Name: cate9105.html, Size: 7KB, Last Modified: Tuesday, March 06, 2007 at 6:43:34 PM

19. AEGiS-AP: Montel to Urge N.J. on Medical Marijuana (35%)
Abstract: Trenton, N.J. (AP) -- Television personality Montel Williams plans to tell a New Jersey senate panel on Thursday how marijuana relieves his chronic pain caused by multiple sclerosis, and urge New Jersey lawmakers to enact medical marijuana laws, as 11 other states already have. Williams, 49, who was diagnosed with MS s ...
http://www.aegis.org/news/ap/2006/ap060621.html
File Name: ap060621.html, Size: 10KB, Last Modified: Tuesday, June 06, 2006 at 3:00:00 PM

20. AEGiS-AP: New Jersey to consider legalizing medical marijuana (35%)
Abstract: TRENTON, N.J. - New Jersey would become the 12th state to legalize marijuana for people with debilitating medical conditions under a bill slated to be discussed next month by state lawmakers. Sen. Joseph Vitale, chairman of a Senate health panel, said he s scheduled a June 8 discussion to hear from experts on the bill ...
http://www.aegis.org/news/ap/2006/ap060521.html
File Name: ap060521.html, Size: 9KB, Last Modified: Tuesday, May 09, 2006 at 3:00:00 PM

21. AEGiS-15IAC: AIDS-wasting syndrome in women patients. (35%)
Abstract: BACKGROUND: Malnutrition is common among individuals suffering advanced HIV disease. The purpose of this work was to assess the impact of HIV infection on nutritional status. METHODS: Prospective single-center observational study of 124 pts. Anthropometric parameters (weight, size, and arm muscle circumference, tricipi ...
http://www.aegis.org/conferences/iac/2004/b10417.html
File Name: b10417.html, Size: 6KB, Last Modified: Monday, July 12, 2004 at 6:29:23 AM

22. UNITED STATES: Cracking Down on Illicit Use of AIDS Drug (35%)
Abstract: Law-enforcement agencies nationwide are cracking down on the illicit trade in Serostim, a growth hormone prescribed to fight AIDS wasting syndrome that has found an additional use - as a bodybuilding drug. FDA has approved the use of Serostim for up to 12 weeks, costing about $21,000. But some doctors keep patients on ...
http://www.aegis.org/news/ads/2004/ad040161.html
File Name: ad040161.html, Size: 10KB, Last Modified: Friday, January 23, 2004 at 3:00:00 PM

23. [143] INAPPROPRIATELY LOW SEX-HORMONE BINDING GLOBULIN WITH SEVERELY DEPLETED TOTAL TESTOSTERONE IN TWO HIV-INFECTED PATIENTS ON TRANSDERMAL TESTOSTERONE REPLACEMENT THERAPY, RECOMBINANT GROWTH HORMONE AND OXANDROLONE (35%)
Abstract: Patients 1 and 2 had low testosterone levels in spite of exogenous testosterone replacement. Discontinuation of oxandrolone in both patients, and rGH in patient 1, led to normalization of testosterone levels in patient 1 and the return of morning erections in patient 2. As prior postulated, it is possible that first pa ...
http://www.aegis.org/conferences/lipo/2003/143.html
File Name: 143.html, Size: 7KB, Last Modified: Wednesday, July 09, 2003 at 6:29:23 AM

24. AEGiS-14IAC: Change in cause of death before and after introduction of highly active antiretroviral therapy (HAART) : three general hospitals based study. (35%)
Abstract: <p><b>BACKGROUND:</b> A marked decline in mortality has occured among HIV-infected patients since the introduction of HAART. The precise causes of death in the current area may have changed and need to be better defined. </p> <p><b>METHODS:</b> Our aim was to study the effect of HAART on causes of death. To evaluate ...
http://www.aegis.org/conferences/iac/2002/tupec4751.html
File Name: tupec4751.html, Size: 7KB, Last Modified: Monday, July 08, 2002 at 6:29:23 AM

25. AEGiS-14IAC: Long-term use of recombinant human growth hormone. (35%)
Abstract: <p><b>BACKGROUND:</b> Very few data exist concerning recombinant human growth hormone (rhGH) in the treatment of patients with AIDS wasting syndrome (AWS); even fewer data exist for HIV-associated adipose redistribution syndrome (HARS). Moreover, no data exist with long-term use of rhGH beyond 12 to 24 weeks. </p> < ...
http://www.aegis.org/conferences/iac/2002/b10303.html
File Name: b10303.html, Size: 7KB, Last Modified: Monday, July 08, 2002 at 6:29:23 AM

26. AEGiS-14IAC: Recombinat human growth hormone in AIDS wasting syndrome associated with HAART and nutritional support. (35%)
Abstract: <p><b>BACKGROUND:</b> Wasting syndrome (WS) is the most frequent and late clinical presentation of HIV/AIDS in people of Mexico . The causes were serious: very advanced HIV disease, diarrhea and opportunistic infections and is frequent cause of bad evolution and bad response to treatment with HAART. OBJECTIVES. To co ...
http://www.aegis.org/conferences/iac/2002/b10531.html
File Name: b10531.html, Size: 7KB, Last Modified: Monday, July 08, 2002 at 6:29:23 AM

27. AEGiS-BKREV: AIDS Clinical Review 1995/1996 (35%)
Abstract: This is the 6th annual review published since 1989. Previous volumes have been reviewed in this journal. The book focuses on specific areas in which important new advances have occurred in the epidemiology, diagnosis, therapy, and prevention of HIV infection and HIV-associated complications. Each chapter is a critical ...
http://www.aegis.org/pubs/books/1996/bk960512.html
File Name: bk960512.html, Size: 7KB, Last Modified: Monday, April 01, 2002 at 11:23:20 PM

28. Justices Set Back Use of Marijuana to Treat Illness (35%)
Abstract: The Supreme Court ruled yesterday that federal law allows no medical necessity exception to its prohibition of the distribution of marijuana. The 8-0 decision was seen as a setback, though not a definitive blow, to the medical marijuana movement, which has succeeded in passing ballot initiatives in eight states. The ru ...
http://www.aegis.org/news/ads/2001/ad010820.html
File Name: ad010820.html, Size: 11KB, Last Modified: Tuesday, May 15, 2001 at 3:00:00 PM

29. AEGiS-Glasgow [P146] A CASE MANAGEMENT APPROACH FOR TWO DIABETIC PATIENTS RECEIVING HAART AND RECOMBINANT HUMAN GROWTH HORMONE (SEROSTIMTM) (GH) FOR HIV-ASSOCIATED WASTING (35%)
Abstract: This report would suggest that the use of GH in diabetic patients with HIV associated wasting is manageable given proper monitoring of glucose levels and adequate amounts of daily insulin. Previous data reports have shown that GH may have a negative effect on normal glucose levels. ...
http://www.aegis.org/conferences/hiv-glasgow/2000/p146.html
File Name: p146.html, Size: 5KB, Last Modified: Sunday, October 22, 2000 at 8:12:04 PM

30. AEGiS-Glasgow [P148] THE USE OF RECOMBINANT GROWTH HORMONE IN PATIENTS WITH ABDOMINAL FAT ACCUMULATION (35%)
Abstract: r-hGH[m] is effective in the treatment of AIDS wasting and has shown effectiveness in reducing abdominal fat accumulation. The durability of r-hGH[m] in maintaining these effects is unknown. Further studies are needed to evaluate the long-term effects of r-hGH [m] in patients diagnosed with HARS. ...
http://www.aegis.org/conferences/hiv-glasgow/2000/p148.html
File Name: p148.html, Size: 6KB, Last Modified: Sunday, October 22, 2000 at 8:12:04 PM

 
1 2 3 4 Next
 
AEGiS Search Engine. Status: The Index is up to date.